Mazzarotto, Francesco
 Distribuzione geografica
Continente #
AS - Asia 945
NA - Nord America 845
EU - Europa 382
SA - Sud America 335
AF - Africa 37
OC - Oceania 4
Totale 2.548
Nazione #
US - Stati Uniti d'America 801
SG - Singapore 378
BR - Brasile 283
HK - Hong Kong 175
CN - Cina 150
VN - Vietnam 95
IT - Italia 69
DE - Germania 62
TR - Turchia 57
GB - Regno Unito 56
IE - Irlanda 44
RU - Federazione Russa 42
CA - Canada 24
FI - Finlandia 23
AT - Austria 22
IN - India 20
AR - Argentina 19
BD - Bangladesh 19
FR - Francia 15
MX - Messico 13
ZA - Sudafrica 12
SE - Svezia 10
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 8
ES - Italia 7
IQ - Iraq 7
MA - Marocco 7
UA - Ucraina 7
JP - Giappone 6
PL - Polonia 6
VE - Venezuela 5
AU - Australia 4
DZ - Algeria 4
EG - Egitto 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
CH - Svizzera 3
GT - Guatemala 3
LT - Lituania 3
PY - Paraguay 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AL - Albania 2
BE - Belgio 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IR - Iran 2
JO - Giordania 2
KH - Cambogia 2
KR - Corea 2
NG - Nigeria 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
MU - Mauritius 1
NO - Norvegia 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 2.548
Città #
Hong Kong 175
Singapore 160
Princeton 82
Ashburn 75
Fairfield 50
Los Angeles 48
Istanbul 47
Beijing 43
Dublin 42
Ho Chi Minh City 36
The Dalles 31
Houston 29
São Paulo 29
Redondo Beach 25
San Diego 24
Helsinki 23
Seattle 21
Wilmington 19
Moscow 18
New York 18
San Francisco 18
Dallas 16
Hanoi 16
Des Moines 14
Nuremberg 14
Villa Carcina 14
Belo Horizonte 13
Brescia 13
Ann Arbor 12
Buffalo 12
London 12
Woodbridge 12
Toronto 11
Vienna 11
Cambridge 10
Atlanta 9
Düsseldorf 9
Pontassieve 9
Munich 8
Orem 7
Stockholm 7
Tianjin 7
Brasília 6
Chicago 6
Curitiba 6
Dhaka 6
Guangzhou 6
Lauterbourg 6
Portsmouth 6
Bremen 5
Denver 5
Haiphong 5
Hải Dương 5
Johannesburg 5
Kyiv 5
Milan 5
Montreal 5
Quito 5
Rio de Janeiro 5
Romola 5
Santa Clara 5
Thái Bình 5
Tokyo 5
Baghdad 4
Biên Hòa 4
Boston 4
Brooklyn 4
Charlotte 4
Chennai 4
Fortaleza 4
Goiânia 4
Kilburn 4
Mantova 4
Melbourne 4
Mumbai 4
Sheffield 4
Warsaw 4
Ankara 3
Bogotá 3
Buenos Aires 3
Caxias do Sul 3
Chiswick 3
Duque de Caxias 3
Frankfurt am Main 3
Guaratinguetá 3
Guarulhos 3
Ha Long 3
Hanover 3
Manchester 3
Mexico City 3
Niterói 3
Petrópolis 3
Phoenix 3
Poplar 3
Salt Lake City 3
Salvador 3
Santo André 3
Shanghai 3
Tampa 3
Tashkent 3
Totale 1.486
Nome #
Genome-wide association testing beyond SNPs 103
Comparison of long-term outcome in anthracycline-related versus idiopathic dilated cardiomyopathy: a single centre experience 68
Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center 66
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease 63
Reevaluating the Genetic Contribution of Monogenic Dilated Cardiomyopathy 63
A gene-centric strategy for identifying disease-causing rare variants in dilated cardiomyopathy 62
Advantages and Perils of Clinical Whole-Exome and Whole-Genome Sequencing in Cardiomyopathy 61
Systematic large-scale assessment of the genetic architecture of left ventricular noncompaction reveals diverse etiologies 60
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy 60
Evaluation of gene validity for CPVT and short QT syndrome in sudden arrhythmic death 59
Disease Progression of Hypertrophic Cardiomyopathy: Modeling Using Machine Learning 59
Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy 58
Comprehensive Assessment of Rare Genetic Variation in Dilated Cardiomyopathy Genes in Patients and Controls (vol 101, pg A41, 2015) 58
Genetic determinants of coping, resilience and self-esteem in schizophrenia suggest a primary role for social factors and hippocampal neurogenesis 56
Comprehensive sequencing of dilated cardiomyopathy genes reveals additive effects of multiple genes on disease risk and severity 56
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies 56
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples 54
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 54
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 54
Ion channel dysfunction and fibrosis in atrial fibrillation: Two sides of the same coin 52
ZBTB17 (MIZ1) Is Important for the Cardiac Stress Response and a Novel Candidate Gene for Cardiomyopathy and Heart Failure 51
FineSplice, enhanced splice junction detection and quantification: a novel pipeline based on the assessment of diverse RNA-Seq alignment solutions 51
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 51
Quantifying evidence toward pathogenicity for rare phenotypes: the case of succinate dehydrogenase genes, SDHB and SDHD 51
CLINICAL AND GENETIC CHARACTERISTICS OF FAMILIAL DILATED CARDIOMYOPATHY IN A LARGE UK PROSPECTIVE COHORT 50
EFFECTS OF TRUNCATING VARIANTS IN TITIN ON CARDIAC PHENOTYPE AND LEFT VENTRICULAR REMODELLING IN DILATED CARDIOMYOPATHY 49
Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients with Hypertrophic Cardiomyopathy 49
Contemporary Insights Into the Genetics of Hypertrophic Cardiomyopathy: Toward a New Era in Clinical Testing? 48
Shared genetic pathways contribute to risk of hypertrophic and dilated cardiomyopathies with opposite directions of effect 48
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency 48
Comparison of long-term clinical course and outcome of MYBPC3-versus MYH7-related hypertrophic cardiomyopathy 47
Ion channel dysfunction and fubrosis in atrial fibrillation:Two sides of the same coin 46
INTEGRATED ALLELIC, TRANSCRIPTIONAL, AND PHENOTYPIC DISSECTION OF THE CARDIAC EFFECTS OF TITIN VARIATION IN HEALTH AND DISEASE 45
Temporal trend in age at diagnosis of hypertrophic cardiomyopathy: an analysis of the share registry 44
Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation 44
A machine learning-based risk stratification model for ventricular tachycardia and heart failure in hypertrophic cardiomyopathy 44
Exploring the complex spectrum of dominance and recessiveness in genetic cardiomyopathies 43
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases 43
Titin-truncating variants affect heart function in disease cohorts and the general population 43
Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions 43
Two decades of genetic testing in hypertrophic cardiomyopathy in a single center: The additive value of extended next-generation sequencing panels lies in the early diagnosis of metabolic mimics 41
Arrhythmogenic potential of myocardial disarray in hypertrophic cardiomyopathy: genetic basis, functional consequences and relation to sudden cardiac death 41
Temporal Trend in Age at Diagnosis of Hypertrophic Cardiomyopathy: An Analysis of the Share Registry 40
Genetic ancestry analysis of the Italian founder population carrying the cardiac amyloidosis-causing variant Val122Ile in the transthyretin gene 40
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 39
Re-evaluating the genetic contribution of monogenic dilated cardiomyopathy 38
Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy 37
Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy 36
RE-EVALUATING THE GENETIC CONTRIBUTION OF MONOGENIC DILATED CARDIOMYOPATHY 34
Slower Calcium Handling Balances Faster Cross-Bridge Cycling in Human MYBPC3 HCM 29
Large-scale genome-wide association analyses identify novel genetic loci and mechanisms in hypertrophic cardiomyopathy 28
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 25
Genetic and Phenotypic Characterization of Nexilin (NEXN)–Related Cardiomyopathy 19
Allele-specific expression analysis: pipelines, applications, challenges, and unmet needs 6
Totale 2.613
Categoria #
all - tutte 24.167
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.167


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022330 127 16 2 6 0 18 46 8 13 2 13 79
2022/2023107 41 0 1 4 1 42 2 0 6 9 1 0
2023/2024201 1 2 15 15 5 5 5 4 99 2 0 48
2024/2025845 1 6 6 85 88 49 71 84 80 97 183 95
2025/20261.130 191 266 155 322 174 22 0 0 0 0 0 0
Totale 2.613